Literature DB >> 12074584

Downregulation of beta2-microglobulin in human cord blood somatic stem cells after transplantation into livers of SCID-mice: an escape mechanism of stem cells?

W Beerheide1, M A von Mach, M Ringel, C Fleckenstein, S Schumann, N Renzing, A Hildebrandt, W Brenner, O Jensen, S Gebhard, K Reifenberg, J Bender, F Oesch, J G Hengstler.   

Abstract

Adherently growing, non-hematopoietic somatic stem cells isolated from human cord blood were stained with the fluorescent dye PKH26 and transplanted into livers of SCID-mice to examine a possible cell fate transition. Already 7 days after transplantation stem cells were well integrated into the liver tissue. Human albumin that was not expressed by the stem cells before transplantation was detectable in the host's livers after injection of cord blood stem cells. Human alpha1-antitrypsin was detectable in stem cells already before transplantation and remained positive in the mouse liver. The most interesting observation in this study was the downregulation of human beta2-microglobulin (beta2M) in the stem cells after transplantation: beta2M is expressed constitutively in our cord blood stem cells. However, beta2M was no longer detectable by RT-PCR in all tissues where human albumin and alpha1-antitrypsin were expressed after stem cell transplantation. beta2M is known to participate as an integral part of the major histocompatibility complex. Absence of beta2M makes the residual heavy chain inactive as an antigen. Thus, downregulation of beta2M may represent an escape mechanism from killer-T cells and may be a molecular mechanism explaining the recently described "immunological blindness" [37] of stem cells. In contrast to the results obtained after direct injection of stem cells as a suspension, no consistent downregulation of beta2M was observed after transplantation of stem cells encapsulated in alginate beads to generate a compartment where stem cells are protected from the host's natural killer cells. No expression of human genes was observed after transplantation of human cord blood derived mononuclear cells (MNC) that were used as a negative control. In conclusion, we have shown that human cord blood somatic stem cells survive and are reprogrammed after transplantation into mouse livers, although a complete transdifferentiation to hepatocytes did not occur within 7 days, since some marker genes (GATA4 and alpha-fetoprotein) were still negative. Switching off expression of beta2M may be part of an intriguing and novel mechanism explaining why stem cells escape the host's immune system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074584     DOI: 10.1016/S0006-291X(02)00596-X

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells.

Authors:  P A Lysy; D Campard; F Smets; J Malaise; M Mourad; M Najimi; E M Sokal
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

3.  Liver stem cells.

Authors:  Neil D Theise
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens.

Authors:  Nicolas Brezillon; Dina Kremsdorf; Mary C Weiss
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

5.  Tracking of human cells in mice.

Authors:  Wiebke Schormann; Friedrich J Hammersen; Marc Brulport; Matthias Hermes; Alexander Bauer; Claudia Rudolph; Markus Schug; Thomas Lehmann; Andreas Nussler; Hendrik Ungefroren; James Hutchinson; Fred Fändrich; Jörg Petersen; Karsten Wursthorn; Martin R Burda; Oliver Brüstle; Kannan Krishnamurthi; Marc von Mach; Jan G Hengstler
Journal:  Histochem Cell Biol       Date:  2008-04-19       Impact factor: 4.304

6.  Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo.

Authors:  B Reder-Hilz; M Ullrich; M Ringel; N Hewitt; D Utesch; F Oesch; J G Hengstler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-04       Impact factor: 3.000

7.  Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro.

Authors:  Tomoharu Tamagawa; Satoshi Oi; Isamu Ishiwata; Hiroshi Ishikawa; Yukio Nakamura
Journal:  Hum Cell       Date:  2007-08       Impact factor: 4.174

Review 8.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

9.  Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat.

Authors:  M Muraca; C Ferraresso; M T Vilei; A Granato; M Quarta; E Cozzi; M Rugge; K A Pauwelyn; M Caruso; I Avital; D Inderbitzin; A A Demetriou; S J Forbes; G Realdi
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

Review 10.  Short review on human umbilical cord lining epithelial cells and their potential clinical applications.

Authors:  Razwa Saleh; Hasan Mahmud Reza
Journal:  Stem Cell Res Ther       Date:  2017-10-10       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.